Expanding presence in Singapore
Since entering the Singaporean market in 2016, through the acquisition of Singapore Oncology Consultants, Icon has significantly expanded its footprint and strengthened its presence.
What began as four centres has grown to seven cancer centres and the upcoming launch of an eighth centre, focused on paediatric oncology. This strategic growth not only showcases Icon’s commitment to expanding access to high-quality cancer care but also highlights its contribution and impact on cancer care in the region.
Partnerships and regional growth
Icon Singapore has expanded its services into regional markets in 2024. Notable initiatives include a newly established centre at Island Hospital in Penang, Malaysia with our strategic partners, Sunsuria Healthcare and collaborative relationships with hospital partners in Indonesia, Vietnam, and Cambodia to provide shared cancer care.
This regional collaborative approach allows Icon to extend its model of high-quality care and expertise to a broader patient base while nurturing cross-border healthcare partnerships.
Growth in clinical expertise
A key aspect of Icon’s success in the region is robust growth in clinical expertise and workforce.
From an initial team of approximately 60 employees in 2016, Icon Singapore now has more than 140 team members. Icon Singapore’s oncologists, haematologists and health screening physician team has grown from seven to 18, further supported by over 80 visiting surgeons and physicians to deliver holistic, multidisciplinary care.
